Determinants and consequences of low vitamin D in populations of African descent ( VIDA )

Cette étude de cohorte, débutée en 2011 (alors appelée METS en 2011—2013), s’effectue dans 5 pays (USA, Jamaïque, Ghana, Afrique du Sud, et Seychelles). Elle est menée par l’université de Loyola (USA). Cette étude poursuit le suivi de l’étude METS (4 Oct 2009-28 Feb 2013  financée par NIH R01-DK080763-01 et est actuellement financée par le NIH 1R01-DK090360 (01.07.2013-30.6.2016). La composante aux Seychelles est gérée par l’IUMSP (Dr Bovet) avec le soutien de  l’unité des maladies cardiovasculaires (UPCCD) du ministère de la santé des Seychelles. Cette étude inclut 500 adultes âgés de 25 à 45 ans à l’enrôlement dans chaque centre (total n=2500). Tous les participants sont revus et soumis à des investigations chaque année. L’étude examine la relation entre l’activité physique objectivement mesurée (accélérométrie, eau doublement marquée) et l’incidence du surpoids et de diabète. Cette étude inclut aussi plusieurs sous-études examinant la nutrition (rappels alimentaires de 24 heures), le rôle de la vitamine D, l’exposition aux métaux, et d’autres facteurs liés aux MNT.


The availability of data on plasma 25-Hydroxyvitamin D (25(OH)D) concentrations in the last two rounds of the National Health and Nutrition Examination Survey (NHANES) has generated a high level of interest in the consequences of 25(OH)D deficiency and in particular its potential impact on black Americans. Fundamental new questions about the biology of vitamin D have now come to the fore. Are low 25(OH)D-intact parathyroid hormone (iPTH) levels a physiologic "abnormality" in African Americans or does the 25(OH)D-iPTH system have sufficient plasticity to adapt to low sunlight exposure? Could the low 25(OH)D levels which result from the "gene- environment discordance" observed in dark skinned populations in the US be a risk factor for metabolic disorders? Ultimately, the public health community and regulatory bodies must offer recommendations for optimal levels and supplementation. The investigators propose to utilize cohorts from an ongoing NIH-funded study designed to identify determinants of weight change and cardiovascular disease risk in five Afro-origin populations [Modeling the Epidemiologic Transition Study (METS)] to examine these questions. The five METS countries include Ghana, Seychelles, South Africa, Jamaica and the US; the five populations differ greatly in terms of sun exposure and dietary intakes. In addition to the extensive energy expenditure, dietary intake and obesity-related metabolic markers being measured in METS, the investigators propose to assess plasma 25(OH)D, iPTH, serum and urinary calcium, plasma markers of bone resorption and formation, and quantitative ultrasound of the calcaneus. The associations of adiposity, weight change, cardiovascular disease (CVD) risk factors such as blood pressure and insulin, and bone strength with 25(OH)D and iPTH will be assessed. The proposed study will provide a comprehensive assessment of the distribution and determinants of 25(OH)D-iPTH and related physiologic measures across a wide range of latitude and lifestyles. These data should contribute substantially to the understanding of the "normal" range within which these hormones function and their significance in Afro- origin populations.

Source : ClinicalTrials.gov

Début du projet: 
Juillet, 2014
Fin du projet: 
Juin, 2017
Clinical Trials registry number (NCT Number): 
Co-requérants du projet (IUMSP): 
Personne de contact (IUMSP): 
Requérant principal ou responsable du projet (non IUMSP): 
Durazo-Arvizu R, Loyola University, Chicago
Co-requérants du projet (non IUMSP): 
Luke A et al (Chicago), Forrester T (Jamaica), Plange-Rhule J (Ghana), Lambert V (South Africa)
                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | iumsp@chuv.ch

Go to top